|
SENP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.943900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.532000E-01 |
| Normal-vs-Stage2 |
1.786340E-02 |
| Normal-vs-Stage3 |
2.567600E-04 |
| Normal-vs-Stage4 |
7.143000E-03 |
| Stage1-vs-Stage2 |
5.061600E-02 |
| Stage1-vs-Stage3 |
6.198100E-04 |
| Stage1-vs-Stage4 |
2.292500E-02 |
| Stage2-vs-Stage3 |
6.837000E-01 |
| Stage2-vs-Stage4 |
8.934200E-01 |
| Stage3-vs-Stage4 |
5.241000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.124970E-03 |
| Normal-vs-AfricanAmerican |
8.430600E-01 |
| Normal-vs-Asian |
3.046600E-01 |
| Caucasian-vs-AfricanAmerican |
3.184100E-02 |
| Caucasian-vs-Asian |
1.567170E-01 |
| AfricanAmerican-vs-Asian |
2.918400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.827200E-04 |
| Normal-vs-Female |
2.618000E-01 |
| Male-vs-Female |
1.318280E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.757700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.737900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.215980E-02 |
| Normal-vs-Age(81-100Yrs) |
6.118000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.717800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.169200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.080800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.561600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.342600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.133200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.510400E-02 |
| Normal-vs-Grade 2 |
1.978580E-01 |
| Normal-vs-Grade 3 |
8.001800E-04 |
| Normal-vs-Grade 4 |
2.763200E-03 |
| Grade 1-vs-Grade 2 |
3.054300E-02 |
| Grade 1-vs-Grade 3 |
4.863100E-03 |
| Grade 1-vs-Grade 4 |
6.141400E-03 |
| Grade 2-vs-Grade 3 |
7.559300E-03 |
| Grade 2-vs-Grade 4 |
1.906040E-02 |
| Grade 3-vs-Grade 4 |
5.146400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.470400E-01 |
| Normal-vs-ccB subtype |
1.786250E-04 |
| ccA subtype-vs-ccB subtype |
1.181140E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.364500E-03 |
| Normal-vs-N1 |
2.739800E-01 |
| N0-vs-N1 |
8.276400E-01 |
|
|
